Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Virol ; 94(1)2019 12 12.
Article in English | MEDLINE | ID: mdl-31619550

ABSTRACT

The major obstacle to human immunodeficiency type 1 virus (HIV-1) eradication is a reservoir of latently infected cells that persists despite long-term antiretroviral therapy (ART) and is maintained through cellular proliferation. Long-lived memory CD4+ T cells with high self-renewal capacity, such as central memory (CM) T cells and stem cell memory (SCM) T cells, are major contributors to the viral reservoir in HIV-infected individuals on ART. The Wnt/ß-catenin signaling pathway regulates the balance between self-renewal and differentiation of SCM and CM T cells, and pharmacological manipulation of this pathway offers an opportunity to interfere with the proliferation of latently infected cells. Here, we evaluated in vivo a novel approach to inhibit self-renewal of SCM and CM CD4+ T cells in the rhesus macaque (RM) model of simian immunodeficiency (SIV) infection. We used an inhibitor of the Wnt/ß-catenin pathway, PRI-724, that blocks the interaction between the coactivator CREB-binding protein (CBP) and ß-catenin, resulting in the cell fate decision to differentiate rather than proliferate. Our study shows that PRI-724 treatment of ART-suppressed SIVmac251-infected RMs resulted in decreased proliferation of SCM and CM T cells and modified the SCM and CM CD4+ T cell transcriptome toward a profile of more differentiated memory T cells. However, short-term treatment with PRI-724 alone did not significantly reduce the size of the viral reservoir. This work demonstrates for the first time that stemness pathways of long-lived memory CD4+ T cells can be pharmacologically modulated in vivo, thus establishing a novel strategy to target HIV persistence.IMPORTANCE Long-lasting CD4+ T cell subsets, such as central memory and stem cell memory CD4+ T cells, represent critical reservoirs for human immunodeficiency virus (HIV) persistence despite suppressive antiretroviral therapy. These cells possess stem cell-like properties of enhanced self-renewal/proliferation, and proliferation of latently infected memory CD4+ T cells plays a key role in maintaining the reservoir over time. Here, we evaluated an innovative strategy targeting the proliferation of long-lived memory CD4+ T cells to reduce viral reservoir stability. Using the rhesus macaque model, we tested a pharmacological inhibitor of the Wnt/ß-catenin signaling pathway that regulates T cell proliferation. Our study shows that administration of the inhibitor PRI-724 decreased the proliferation of SCM and CM CD4+ T cells and promoted a transcriptome enriched in differentiation genes. Although the viral reservoir size was not significantly reduced by PRI-724 treatment alone, we demonstrate the potential to pharmacologically modulate the proliferation of memory CD4+ T cells as a strategy to limit HIV persistence.


Subject(s)
Bridged Bicyclo Compounds, Heterocyclic/pharmacology , CD4-Positive T-Lymphocytes/drug effects , Cell Proliferation/drug effects , Immunologic Memory/drug effects , Pyrimidinones/pharmacology , Signal Transduction/drug effects , Simian Acquired Immunodeficiency Syndrome/drug therapy , Animals , Antiretroviral Therapy, Highly Active/methods , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/virology , CREB-Binding Protein/antagonists & inhibitors , CREB-Binding Protein/genetics , CREB-Binding Protein/immunology , Cell Differentiation/drug effects , DNA, Viral/antagonists & inhibitors , DNA, Viral/genetics , DNA, Viral/immunology , Emtricitabine/pharmacology , Female , Gene Expression Regulation , Heterocyclic Compounds, 3-Ring/pharmacology , Host-Pathogen Interactions/genetics , Host-Pathogen Interactions/immunology , Immunologic Memory/genetics , Macaca mulatta , Male , Oxazines , Piperazines , Pyridones , Signal Transduction/genetics , Signal Transduction/immunology , Simian Acquired Immunodeficiency Syndrome/genetics , Simian Acquired Immunodeficiency Syndrome/immunology , Simian Acquired Immunodeficiency Syndrome/pathology , Simian Immunodeficiency Virus/drug effects , Simian Immunodeficiency Virus/immunology , Simian Immunodeficiency Virus/pathogenicity , Stem Cells/drug effects , Stem Cells/immunology , Stem Cells/virology , Tenofovir/pharmacology , Viral Load/drug effects , Virus Latency , Virus Replication/drug effects , Wnt Signaling Pathway/drug effects , beta Catenin/antagonists & inhibitors , beta Catenin/genetics , beta Catenin/immunology
2.
Mucosal Immunol ; 10(4): 996-1007, 2017 07.
Article in English | MEDLINE | ID: mdl-27848950

ABSTRACT

Most HIV transmissions among men who have sex with men (MSM), the group that accounted for 67% of new US infections in 2014, occur via exposure to the rectal mucosa. However, it is unclear how the act of condomless receptive anal intercourse (CRAI) may alter the mucosal immune environment in HIV-negative MSM. Here, we performed a comprehensive characterization of the rectal mucosal immune environment for the phenotype and production of pro-inflammatory cytokines by CD4 and CD8 T cells, global transcriptomic analyses, and the composition of microbiota in HIV-negative MSM. Our results show that compared with men who had never engaged in anal intercourse, the rectal mucosa of MSM engaging in CRAI has a distinct phenotype characterized by higher levels of Th17 cells, greater CD8+ T cell proliferation and production of pro-inflammatory cytokines, molecular signatures associated with mucosal injury and repair likely mediated by innate immune cells, and a microbiota enriched for the Prevotellaceae family. These data provide a high-resolution model of the immunological, molecular, and microbiological perturbations induced by CRAI, will have direct utility in understanding rectal HIV transmission among MSM, and will enhance the design of future biomedical prevention interventions, including candidate HIV vaccines.


Subject(s)
Bacteroidaceae Infections/immunology , CD8-Positive T-Lymphocytes/immunology , HIV Infections/immunology , Microbiota/genetics , Mucous Membrane/immunology , Prevotella/genetics , Rectum/pathology , Th17 Cells/immunology , Adult , Cell Proliferation , Condoms/statistics & numerical data , Cytokines/metabolism , HIV Infections/prevention & control , HIV Infections/transmission , HIV Seronegativity , Homosexuality, Male , Humans , Inflammation Mediators/metabolism , Male , Sexual Behavior , Transcriptome , Young Adult
3.
Am J Transplant ; 16(4): 1102-12, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26603381

ABSTRACT

Belatacept is a B7-specific fusion protein used to prevent allograft rejection by blocking T cell costimulation. Generally efficacious, it fails to prevent acute rejection in a sizable minority of patients. In experimental models, memory T cells mediate costimulation blockade-resistant rejection (CoBRR), but this remains undefined in humans. To explore relationships between individual patients' immune cell phenotypes and CoBRR, we studied patients receiving belatacept or conventional calcineurin inhibitor-based immunosuppression. We identified a population of CD57(+) PD1(-) CD4 T cells present prior to transplantation that correlated with CoBRR. Contrary to data recognizing CD57 as a marker of senescence on CD8 T cells, we discovered a nonsenescent, cytolytic phenotype associated with CD57 on CD4 T cells. Moreover, CD57(+) CD4 T cells expressed high levels of adhesion molecules implicated in experimental CoBRR, were CD28(-) , expressed a transcriptional phenotype broadly defining allograft rejection and were shown to be present in rejecting human kidney allografts. These data implicate CD57(+) CD4 T cells in clinical CoBRR. If prospectively validated, this characteristic could identify patients at higher risk for acute rejection on belatacept-based therapy.


Subject(s)
Abatacept/therapeutic use , CD4-Positive T-Lymphocytes/immunology , CD57 Antigens/metabolism , Graft Rejection/immunology , Immunosuppressive Agents/therapeutic use , Kidney Transplantation , Adult , Allografts , Drug Resistance , Flow Cytometry , Follow-Up Studies , Glomerular Filtration Rate , Graft Rejection/prevention & control , Graft Survival/immunology , Humans , Immunohistochemistry , Immunologic Memory , Kidney Failure, Chronic/surgery , Kidney Function Tests , Oligonucleotide Array Sequence Analysis , Polymerase Chain Reaction , Prognosis , Risk Factors
4.
J Virol ; 89(18): 9167-77, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26109722

ABSTRACT

UNLABELLED: Our earlier studies with pig-tailed macaques demonstrated various simian-human immunodeficiency virus (SHIV) susceptibilities during the menstrual cycle, likely caused by cyclic variations in immune responses in the female genital tract. There is concern that high-dose, long-lasting, injectable progestin-based contraception could mimic the high-progesterone luteal phase and predispose women to human immunodeficiency type 1 (HIV-1) acquisition and transmission. In this study, we adopted a systems biology approach employing proteomics (tandem mass spectrometry), transcriptomics (RNA microarray hybridization), and other specific protein assays (enzyme-linked immunosorbent assays and multiplex chemokine and cytokine measurements) to characterize the effects of hormonal changes on the expression of innate factors and secreted proteins in the macaque vagina. Several antiviral factors and pathways (including acute-phase response signaling and complement system) were overexpressed in the follicular phase. Conversely, during the luteal phase there were factors overexpressed (including moesins, syndecans, and integrins, among others) that could play direct or indirect roles in enhancing HIV-1 infection. Thus, our study showed that specific pathways and proteins or genes might work in tandem to regulate innate immunity, thus fostering further investigation and future design of approaches to help counter HIV-1 acquisition in the female genital tract. IMPORTANCE: HIV infection in women is poorly understood. High levels of the hormone progesterone may make women more vulnerable to infection. This could be the case during the menstrual cycle, when using hormone-based birth control, or during pregnancy. The biological basis for increased HIV vulnerability is not known. We used an animal model with high risk for infection during periods of high progesterone. Genital secretions and tissues during the menstrual cycle were studied. Our goal was to identify biological factors upregulated at high progesterone levels, and we indeed show an upregulation of genes and proteins which enhance the ability of HIV to infect when progesterone is high. In contrast, during low-progesterone periods, we found more HIV inhibitory factors. This study contributes to our understanding of mechanisms that may regulate HIV infection in females under hormonal influences. Such knowledge is needed for the development of novel prevention strategies.


Subject(s)
Antiviral Agents/immunology , Estrous Cycle , HIV Infections/immunology , HIV-1/immunology , Immunity, Innate , Vagina/immunology , Animals , Disease Susceptibility/immunology , Female , HIV Infections/transmission , Humans , Macaca nemestrina , Risk Factors , Systems Biology
5.
Nat Immunol ; 1(3): 227-33, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10973280

ABSTRACT

Chemoattractant-stimulated granule release from neutrophils, basophils and eosinophils is critical for the innate immune response against infectious bacteria. Interleukin 8 (IL-8) activation of the chemokine receptor CXCRI was found to stimulate rapid formation of beta-arrestin complexes with Hck or c-Fgr. Formation of beta-arrestin-Hck complexes led to Hck activation and trafficking of the complexes to granule-rich regions. Granulocytes expressing a dominant-negative beta-arrestin-mutant did not release granules or activate tyrosine kinases after IL-8 stimulation. Thus, beta-arrestins regulate chemokine-induced granule exocytosis, indicating a broader role for beta-arrestins in the regulation of cellular functions than was previously suspected.


Subject(s)
Arrestins/physiology , Cytoplasmic Granules/metabolism , Protein-Tyrosine Kinases/metabolism , Receptors, Interleukin-8A/physiology , Amino Acid Sequence , Arrestins/genetics , Arrestins/metabolism , Cell Degranulation , Enzyme Activation , Granulocytes/immunology , Granulocytes/metabolism , Humans , Interleukin-8/pharmacology , Molecular Sequence Data , Protein-Tyrosine Kinases/physiology , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins/physiology , Proto-Oncogene Proteins c-hck , Receptors, Interleukin-8A/genetics , Receptors, Interleukin-8A/metabolism , Transfection , beta-Arrestins , src-Family Kinases
SELECTION OF CITATIONS
SEARCH DETAIL
...